The use of pharmacogenomic testing (PGT) removes the “one size fits all” approach to drug therapy and tailors it to the individual patient’s genomic profile to assist in the most effective therapy with the least amount of side effects. This will, in turn, increase drug adherence, leading to reduced healthcare costs (for patient and healthcare system) and improved patient outcomes.
Let’s start to make a difference for our patients and improve overall health outcomes.
Join us for a continuing education course on July 6. We will define pharmacogenomics and discuss clinical significance. We will identify key features of pharmacogenomics as it relates to clinical validity and utility. We will examine current use and barriers of pharmacogenomic testing and interpret ethical and legal implications for clinical use.
Tuesday, July 6, 2021
10-11:30 a.m. CT
Creighton University College of Nursing
Creighton University School of Pharmacy and Health Professions
Creighton University Office of Continuing Education
Physicians, Nurse Practitioners, Physician Assistants, Pharmacists, Nurses, Fellows, Residents, Students, and Other Interested Healthcare Professionals
Trina Walker, DNP, APRN, FNP-C, assistant professor for the College of Nursing Doctor of Nursing Practice (DNP) Family Nurse Practitioner track. Dr. Walker has been extensively involved with developing pharmacogenomics content for prescribing professionals since the inception of her doctoral education at Creighton University nearly eight years ago. Her research trajectory includes incorporation of pharmacogenomics into clinical practice, as well as integration of genetics/genomics into undergraduate and graduate curricula.
Somnath Singh, BPharm, MPharm, PhD, Professor of Pharmaceutical Sciences, Director for Graduate Program in Pharmaceutical Sciences, Pharmacy Sciences Department, School of Pharmacy and Health Professions, Creighton University. Singh has been teaching Pharmacogenomics in Disease Management course to Pharm D students since 2004. This course provides the basics of pharmacogenomics principles essential for understanding and applying it in medication therapy management. Specific examples of drugs are used for which FDA recommends pharmacogenomic testing and profiling.
Michael Schooff, MD, FAAFP
Chris Destache, PharmD
Learn more with Creighton’s online program “Pharmacogenomics in Practice: Act Now.” Register today!